Discover 859 paid clinical trials in Kansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
GB002, Inc.
Location:
Code:
NCT05934526
Conditions
Pulmonary Arterial Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Seralutinib
Generic Dry Powder Inhaler
Sponsor:
Target PharmaSolutions, Inc.
Location:
Code:
NCT03661866
Conditions
Atopic Dermatitis
Alopecia Areata
Hidradenitis Suppurativa
Vitiligo
Psoriasis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06393374
Conditions
Triple-Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
sac-TMT
Capecitabine
Sponsor:
Vanda Pharmaceuticals
Location:
Code:
NCT03838926
Conditions
Relapsed or Refractory Hematologic Malignancies
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Trichostatin A
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
Sponsor:
University of Kansas
Location:
Code:
NCT05190926
Conditions
Anorexia Nervosa
Eligibility Criteria
Sex: All
Age: 13 - 21
Healthy Volunteers: Not accepted
Interventions
Smart-Treatment for Anorexia Nervosa Recovery (STAR)
Present-focused Anorexia Nervosa Coping Treatment (PACT)
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT06003426
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
BMS-986278
BMS-986278 Placebo
Sponsor:
Genmab
Location:
Code:
NCT05579366
Conditions
Platinum-Resistant Ovarian Cancer
Platinum Sensitive Ovarian Cancer (PSOC)
High Grade Epithelial Ovarian Cancer
High Grade Serous Ovarian Cancer
Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PRO1184
PRO1184 intravenous infusion of PRO1184
Sponsor:
Arog Pharmaceuticals, Inc.
Location:
Code:
NCT03258931
Conditions
Newly Diagnosed FLT3 Mutated AML
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Crenolanib
Midostaurin
Cytarabine
Duanorubicin
With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.
These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.
Kansas offers unique advantages for those participating in clinical trials. The state’s central location, combined with a mix of urban and rural populations, provides a diverse range of participants, making research findings more comprehensive and applicable to various communities. Kansas is also known for its collaborative research environment, where major institutions work closely with local healthcare providers to drive medical advancements.
By participating in a clinical trial in Kansas, volunteers contribute to critical research efforts while benefiting from a supportive, patient-focused clinical research system that emphasizes innovation and community engagement.
Kansas plays a crucial role in clinical research, focusing on several key medical conditions that not only affect local populations but also contribute to global advancements in healthcare.
Researchers in Kansas focus on both pharmacological treatments and lifestyle interventions, such as diet and exercise, when it comes to neurological research and slowing the progression of these diseases. With neurodegenerative diseases becoming more prevalent due to aging populations, the research conducted in Kansas is crucial for shaping future therapies and preventive measures.
The University of Kansas Alzheimer’s Disease Research Center (KU ADRC) is a leader in exploring the causes and potential treatments for Alzheimer’s disease, dementia, and other neurological disorders like Parkinson’s and multiple sclerosis (MS). Kansas has earned a reputation in the medical community for its clinical trials on cognitive decline and brain aging.
The Midwest, including Kansas, has some of the highest rates of Type 2 diabetes, which makes the state a critical location for diabetes research. Clinical trials in Kansas explore a variety of approaches to managing both Type 1 and Type 2 diabetes, including new drug therapies, insulin delivery methods, and interventions to prevent complications such as neuropathy and cardiovascular damage.
Institutions like The University of Kansas Medical Center and Wesley Medical Center are involved in large-scale studies that investigate how metabolic disorders can be better managed and potentially reversed through innovative therapies. These trials are crucial as diabetes continues to rise, both in Kansas and globally.
Kansas is renowned for its research efforts in rare diseases and pediatric research. In particular, Children’s Mercy Kansas City is internationally recognized for its focus on rare diseases and pediatric conditions. It leads numerous clinical trials in targeting genetic and metabolic disorders that are often under-researched due to their rarity. For example, the hospital is involved in trials for cystic fibrosis, Duchenne muscular dystrophy, and rare autoimmune disorders.
Children’s Mercy has also developed a strong reputation for using genomics to tailor treatments for children with complex health conditions. Kansas’ contributions to rare disease research are pivotal, as they often provide new hope for children and families facing conditions for which there are limited treatment options.
In Kansas, researchers place a strong focus on early detection, personalized medicine, and immunotherapy, placing Kansas at the cutting edge of oncology research. The University of Kansas Cancer Center (KUCC) is one of only 72 National Cancer Institute-designated cancer centers in the U.S., recognized for its excellence in research, prevention, and treatment.
KUCC is known for groundbreaking studies in breast, prostate, leukemia, lung, and colorectal cancer, which are among the most prevalent cancers in the region. The work conducted at KUCC has helped improve treatment protocols and survival rates for patients, not just in Kansas but worldwide, by leading clinical trials for new therapies and drugs.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Kansas is home to some of the nation’s leading cardiovascular research programs, particularly through partnerships with hospitals like The University of Kansas Medical Center and Stormont Vail Health. Clinical trials focus on heart failure, atrial fibrillation, hypertension, and innovative procedures such as minimally invasive valve replacements.
Kansas is also heavily involved in studying preventative measures for heart disease, stroke recovery, and cardiac rehabilitation, helping to develop advanced treatment methods and lifestyle interventions. Given that heart disease is one of the leading causes of death in the U.S., Kansas’ contributions to cardiovascular research are vital for improving health outcomes across the nation.
Clinical trials in Kansas are governed by both federal and state regulations that protect participants and ensure ethical research practices. Oversight is primarily provided by the FDA and Institutional Review Boards (IRBs), which ensure compliance with federal standards like Good Clinical Practice (GCP) and informed consent requirements.
Kansas-specific regulations, including state statutes on human research, also contribute to ensuring trials are conducted ethically and safely. Key medical research institutions follow strict protocols to protect vulnerable populations, such as children and individuals with cognitive impairments while safeguarding participants' privacy through HIPAA and local privacy laws.
Joining a clinical trial gives individuals the chance to explore new, innovative treatments and therapies that may not yet be available to the public. This is particularly beneficial for those with conditions that haven’t responded to conventional care or currently available treatments. Participants receive specialized attention from medical professionals who monitor their health closely to ensure both safety and treatment effectiveness.
Beyond personal benefits, clinical trial participation plays a crucial role in advancing medical science. By taking part, individuals help drive the development of new treatments and contribute to improving healthcare outcomes worldwide. This involvement can lead to breakthroughs that shape the future of medicine and offer hope to countless patients.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: